Mid Cap
Medical Devices
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Insulet
PODD
$9.8B
| $9.8B | $141.10 | 1.68% |
|
2
Bio-Rad Laboratories Class B
BIO.B
$9.7B
| $9.7B | – | – |
|
3
Glaukos
GKOS
$9.7B
| $9.7B | $164.84 | 0.46% |
|
|
4
Bio-Rad Laboratories Class A
BIO
$9.46B
| $9.46B | $353.70 | 3.05% |
|
5
10x Genomics
TXG
$9.1B
| $9.1B | $69.86 | 3.49% |
|
6
Bruker
BRKR
$8.35B
| $8.35B | $54.80 | 3.08% |
|
7
Haemonetics
HAE
$5.38B
| $5.38B | $118.28 | 2.48% |
|
8
Integer Holdings
ITGR
$4.31B
| $4.31B | $126.70 | 0.02% |
|
9
LivaNova
LIVN
$4.27B
| $4.27B | $77.58 | 1.17% |
|
10
iRhythm Holdings
IRTC
$3.58B
| $3.58B | $108.66 | 0.63% |
|
11
Neogen
NEOG
$2.58B
| $2.58B | $11.81 | 3.75% |
|
12
Transmedics
TMDX
$2.45B
| $2.45B | $70.78 | 7.5% |
|
13
UFP Technologies
UFPT
$2.26B
| $2.26B | $291.67 | 1.86% |
|
14
Axogen
AXGN
$2.03B
| $2.03B | $34.62 | 2.83% |
|
Mid Cap Medical Devices Stocks at a Glance
Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.
There are 14 mid cap Medical Devices stocks — companies in the Medical Devices industry with a market cap between $2B and $10B — worth a combined $83B.
The largest by market cap are Insulet (PODD) at $9.8B, Bio-Rad Laboratories Class B (BIO.B) at $9.7B and Glaukos (GKOS) at $9.7B.
Among institutional investors, Bruker (BRKR) drew the most net new fund positions in Q2 2026: 118 funds opened new positions, taking total fund holders up 72 (21%) quarter-over-quarter.
- Combined market cap: $83B across 14 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Insulet (PODD), $9.8B market cap.
- Most net new fund positions in Q2 2026: Bruker (BRKR), +72 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.